Measurement of Residual Cancer Burden in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Correlation with Biomarker Expression and Molecular Subtypes

被引：0

作者：

Cockburn, A. ^{[1
]}

Peng, Y. ^{[1
]}

Euhus, D. ^{[1
]}

Haley, B. ^{[1
]}

Sarode, V. ^{[1
]}

机构：

[1] Univ Texas SW, Dallas, TX USA

来源：

MODERN PATHOLOGY | 2011年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

129

引用

页码：33A / 33A

页数：1

共 50 条

[41] The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy
Xin Xu
Wei Zhao
Cuicui Liu
Yongsheng Gao
Dawei Chen
Meng Wu
Chao Li
Xinzhao Wang
Xiang Song
Jinming Yu
Zhaoyun Liu
Zhiyong Yu
BMC Cancer, 24
[42] Pathological measurement and staging of residual breast cancer after neoadjuvant chemotherapy
Harter, Dawn
O'Connor, Siobhan M.
Hertel, Johann D.
Calhoun, Benjamin C.
HISTOPATHOLOGY, 2023, 83 (03) : 453 - 464
[43] Molecular analysis in breast cancer subtypes and correlation with pathologic complete response (pCR) to neoadjuvant chemotherapy.
Gonzalez Cao, Maria
Costa, Carlota
Angel Molina-Vila, Miguel
Teresa Cusido, Maria
Viteri Ramirez, Santiago
Baulies, Sonia
Martinez-Bueno, Alejandro
Fabregas, Rafael
Tresserra, Francesc
Sansano, Irene
Ara, Carmen
Amselen, David
Ubeda, Belen
Simo-Perdigo, Marc
Gasco, Amaya
Rodriguez, Ignacio
Rosell, Rafael
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[44] Evaluation of predictive and prognostic value of androgen receptor expression in breast cancer subtypes treated with neoadjuvant chemotherapy
Shi, Zhendong
Liu, Yingxue
Zhang, Shichao
Cai, Shuanglong
Liu, Xu
Meng, Jie
Zhang, Jin
DISCOVER ONCOLOGY, 2023, 14 (01)
[45] Evaluation of predictive and prognostic value of androgen receptor expression in breast cancer subtypes treated with neoadjuvant chemotherapy
Zhendong Shi
Yingxue Liu
Shichao Zhang
Shuanglong Cai
Xu Liu
Jie Meng
Jin Zhang
Discover Oncology, 14
[46] Modulatory effect of neoadjuvant chemotherapy on biomarkers expression; assessment by digital image analysis and relationship to residual cancer burden in patients with invasive breast cancer
Cockburn, Amber
Yan, Jingsheng
Rahardja, Dewi
Euhus, David
Peng, Yan
Fang, Yisheng
Sarode, Venetia Rumnong
HUMAN PATHOLOGY, 2014, 45 (02) : 249 - 258
[47] The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation
Yang, T. Jonathan
Morrow, Monica
Modi, Shanu
Zhang, Zhigang
Krause, Kate
Siu, Chun
McCormick, Beryl
Powell, Simon N.
Ho, Alice Y.
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S495 - S501
[48] The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation
T. Jonathan Yang
Monica Morrow
Shanu Modi
Zhigang Zhang
Kate Krause
Chun Siu
Beryl McCormick
Simon N. Powell
Alice Y. Ho
Annals of Surgical Oncology, 2015, 22 : 495 - 501
[49] Predictive Role of Molecular Subtypes in Response to Neoadjuvant Chemotherapy in Breast Cancer Patients in Northeast China
Lv, Minhao
Li, Beibei
Li, Yongfeng
Mao, Xiaoyun
Yao, Fan
Jin, Feng
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (09) : 2411 - 2417
[50] Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy
Yuan, Jia-qi
Wang, Shou-man
Tang, Li-li
Mao, Jie
Wu, Yu-hui
Hai, Jian
Luo, Sha-yang
Ou, Hui-ying
Guo, Lei
Liao, Li-qiu
Huang, Jun
Li, Yan
Xiao, Zhi
Zhang, Ke-jing
Luo, Na
Chen, Fei-yu
BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (02) : 405 - 413

← 1 2 3 4 5 →